Ellington Financial financials
$12.18−0.16%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $1.33B | $1.18B | $1.04B | $87.8M | $179.2M |
| Gross profit | $336.4M | $305.6M | $276.9M | $60.0M | $151.0M |
| Gross margin | 25.3% | 26.0% | 26.6% | 68.3% | 84.3% |
| Operating income | $97.9M | $116.3M | $89.2M | -$25.0M | $84.6M |
| Net income | $120.1M | $119.0M | $61.6M | -$85.3M | $126.2M |
| Net margin | 9.0% | 10.1% | 5.9% | −97.1% | 70.4% |
| Diluted EPS | $1.19 | $1.36 | $0.89 | $-1.43 | $2.58 |
| EBITDA | $97.9M | $116.3M | $89.2M | -$25.0M | $84.6M |
| Operating cash flow | -$925.5M | -$430.5M | -$241.9M | $42.7M | $51.3M |
| Free cash flow | -$925.5M | -$430.5M | -$241.9M | $42.7M | $51.3M |
| Diluted shares | 100.5M | 87.7M | 69.1M | 60.6M | 49.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $201.9M | $192.4M | $228.9M | $217.1M |
| Short-term investments | $1.74B | $1.48B | $1.83B | $1.76B |
| Total debt | $14.31B | $11.62B | $10.12B | $9.79B |
| Total assets | $19.35B | $16.32B | $15.32B | $14.09B |
| Total liabilities | $17.48B | $14.73B | $13.78B | $12.87B |
| Shareholders' equity | $1.87B | $1.59B | $1.54B | $1.22B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology